Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

Vaccine

Volumn 20, Issue 7-8, 2002, Pages 1039-1045

  Gilbert, Sarah C ^a   Schneider, Jörg ^b   Hannan, Carolyn M ^b   Hu, Jiang Ting ^a   Plebanski, Magdalena ^b   Sinden, Robert ^c   Hill, Adrian V S ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Adenoviral vector; Heterologous prime boost; Immunogenicity

Indexed keywords

CD8 ANTIGEN; EPITOPE; MALARIA VACCINE; RECOMBINANT DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; POXVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS EXPRESSION; VIRUS IDENTIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNIZATION, SECONDARY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; VACCINES, DNA; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0037081381     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00450-9     Document Type: Article

References (45)

1. T cell responses to pre-erythrocytic stages of malaria: Role in protection and vaccine development against pre-erythrocytic stages
2. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens
3. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
4. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria
5. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
6. A protein particle vaccine containing multiple malaria epitopes
7. The smallpox vaccination strain MVA: Marker, genetic structure, experience gained with the parental vaccination and behavior in organisms with a debilitated defence mechanism
8. Nonreplicating vaccinia vector efficiently expresses recombinant genes
9. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
10. Ty virus-like particles, DNA vaccines and modified vaccinia virus ankara; comparisons and combinations
11. Methods for construction of adenovirus vectors
12. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
13. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: Protection elicited in a murine model
14. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: Induction of an MHC-1-restricted CTL response and protection in a murine model
15. + T cell-mediated protective immunity against malaria
16. Vaccination onto bare skin
17. Polymorphism of the TRAP gene of Plasmodium falciparum
18. Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP
19. Plasmodium falciparum liver stage antigen-1 is well-conserved and contains potent B and T cell determinants
20. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes
21. A malaria protein exported into a new compartment within the host erythrocyte
22. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria
23. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2
24. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers
25. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: Analysis of human CTL response to most known variants
26. + CTL epitope in naturally exposed Kenyan adults
27. Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: Recognition of processed antigen despite limited re-stimulation efficacy
28. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania
29. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa
30. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization
31. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
32. + T cell-, interferon gamma-, and nitric oxide-dependent immunity
33. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use
34. Immunization with live types 7 and 4 adenovirus vaccines. Part II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7
35. Army trainees US Yale
36. Immunization of Canadian armed forces upersonnel with live types 4 and 7 adenovirus vaccines
37. + T-cell-mediated protective immunity against malaria
38. + T cell responses induced by recombinant influenza and vaccinia viruses
39. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep
40. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein
41. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus
42. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant
43. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime
44. + T cells using heterologous prime-boost immunisation strategies
45. Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis